Items Tagged ‘Rory Smoot’
March 28, 2022
Regenerative Medicine Minnesota awards 5 research grants to Mayo Clinic
Regenerative Medicine Minnesota, a statewide bipartisan initiative, has awarded five grants to Mayo Clinic investigators to advance new therapeutic options for osteoarthritis, liver disease, rotator cuff injuries and neurological birth defects. People in Minnesota and beyond struggle with chronic diseases such as heart disease, arthritis and diabetes, and standard care doesn’t always ease the symptoms. […]
Tags: Aaron Krych, animal model, cartilage, cellular therapy, Center for Regenerative Medicine, Chunfeng Zhao, clinical trials, Jennifer Westendorf, liver failure, mesenchymal stem cells, minimally invasive procedure, molecular biology
June 29, 2020
Research grants aim to advance regenerative medicine toward the practice
Reprogramming human cells to correct blood disorders such as sickle cell disease, activation of a regenerative pathway to treat liver failure and strategies for skeletal regeneration in patients with brittle bone disease are examples of Mayo Clinic research to be funded through new grants from Regenerative Medicine Minnesota. Regenerative Medicine Minnesota, a statewide bipartisan initiative, […]
Tags: clinical trials, Dan Dragomir-Daescu, David Deyle, epigenetics, liver disease, Martin Rodriguez-Porcel, measles virus, nanomedicine, Patricia Devaux, radiation therapy, Regenerative Medicine Minnesota, Rory Smoot
January 22, 2020
What’s Next for The Research of the Future
By Sara Tiner 
Breakthroughs in medical science rarely burst on the scene. Behind every advance is years of work by dogged researchers who nurtured the seed of idea until it flowered, bore fruit and materialized into a better treatment, device or therapy for patients. Here is where those seeds start: More than a dozen projects related to cancer, […]
Tags: Anthony Windebank, basic science, cancer, cancer genomics, Center for Biomedical Discovery, Christopher Evans, Christopher Groen, Daniel Billadeau, Daniel Tschumperlin, discovery research, Eva Morava-Kozicz, fibrosis
November 10, 2015
CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows. […]
Tags: Carlos Puig, Center for the Science of Health Care Delivery, Christopher Shubert, David Nagorney, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, Michael Farnell, Michael Kendrick, pancreatic cancer, Rory Smoot, Ryan Groeschl